Open AccessOx-LDL, Lysophospatidy Choline Platelet Activating Factor, IL-6 Expression Level and Foam Cell Number with Darappabdib Treatment in Early Development of Atherosclerosis: In Vivo Study for Type 2 Diabetes Mellitus Model
Author(s) -
Teuku Heriansyah,
Bambang Budi Siswanto,
Anwar Santoso,
Djanggan Sargowo,
Imam Subekti,
Abasiattai AM,
Renan Sukmawan,
Nuryati Chairani Siregar,
Saptawati Bordosono,
Titin Andri Wihastuti
Publication year - 2016
Language(s) - English
DOI - 10.55503/2790-6744.1025
Subject(s) - foam cell , lysophosphatidylcholine , in vivo , inflammation , platelet activating factor , type 2 diabetes mellitus , insulin resistance , medicine , oxidative stress , platelet , malondialdehyde , type 2 diabetes , diabetes mellitus , endocrinology , chemistry , pharmacology , biology , biochemistry , lipoprotein , cholesterol , phosphatidylcholine , phospholipid , microbiology and biotechnology , membrane